Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Caffeine + L-theanine is a combination of two naturally occurring compounds commonly found together in tea leaves. Caffeine is a central nervous system stimulant that increases alertness and energy by antagonizing adenosine receptors in the brain. L-theanine is an amino acid that promotes relaxation without sedation by modulating neurotransmitter activity—specifically increasing dopamine and reducing serotonin, noradrenaline, GABA release, and acting as a glutamate inhibitor. When combined in supplemental form (often at ratios such as 1:2 or 1:1), this stack provides synergistic effects on cognitive performance—improving attention-switching speed and accuracy, reaction time, sustained focus, mood balance, and reducing susceptibility to distraction compared to either compound alone. The combination also helps mitigate the jitteriness or anxiety sometimes associated with caffeine use while maintaining its benefits for mental clarity and wakefulness[1][3][5]. This blend is widely used as a nootropic supplement for work productivity enhancement, studying support, gaming focus improvement, fitness performance boost (especially during tasks requiring sustained attention), or as an alternative to coffee/energy drinks[6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on caffeine + l-theanine.